Literature DB >> 15802914

Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease.

Daphne M Geslani1, Mary C Tierney, Nathan Herrmann, John P Szalai.   

Abstract

OBJECTIVE: Because of discrepant findings regarding the accuracy of mild cognitive impairment (MCI) in predicting Alzheimer's disease (AD), further study of this construct and conversion rates is essential before use in clinical settings. We aimed to develop an operational definition of MCI consistent with criteria proposed by the Mayo Alzheimer's Disease Center, and to examine its conversion rate to AD.
METHODS: Patients were identified from an inception cohort of patients with at least a 3-month history of memory problems, and referred to a 2-year university teaching hospital investigation by primary care physicians. We classified 161 nondemented patients at baseline using MCI criteria. Diagnostic workups were completed annually, and patients were classified as meeting criteria for AD or showing no evidence of dementia after 1 and 2 years.
RESULTS: Of 161 patients, 35% met MCI criteria at baseline. Conversion rates to AD were 41% after 1 year, and 64% after 2 years. Logistic regression analyses to examine predictive accuracy of MCI after 1 and 2 years, with age and education as covariates, were significant (p < 0.0001). After 1 year, MCI showed an optimal sensitivity of 91% and specificity of 79%, and after 2 years, these values were 88 and 83%, respectively.
CONCLUSIONS: MCI is an accurate predictor of AD over 1 and 2 years in patients referred by their primary care physicians. Discrepancies in conversion rates may be due to the manner in which patients are recruited to studies as well as the use of different measures to operationalize the construct.

Entities:  

Mesh:

Year:  2005        PMID: 15802914     DOI: 10.1159/000084709

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  37 in total

1.  Description and classification of normal and pathological aging processes based on brain magnetic resonance imaging morphology measures.

Authors:  Jorge Luis Perez-Gonzalez; Oscar Yanez-Suarez; Ernesto Bribiesca; Fernando Arámbula Cosío; Juan Ramón Jiménez; Veronica Medina-Bañuelos
Journal:  J Med Imaging (Bellingham)       Date:  2014-10-07

2.  Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study.

Authors:  Hyun Cho; Dong Won Yang; Young Min Shon; Beum Saeng Kim; Yeong In Kim; Young Bin Choi; Kwang Soo Lee; Yong Soo Shim; Bora Yoon; Woojin Kim; Kook Jin Ahn
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

3.  Comparing the effects of clinician and caregiver-administered lexical retrieval training for progressive anomia.

Authors:  Stephanie M Grasso; Kaleigh M Shuster; Maya L Henry
Journal:  Neuropsychol Rehabil       Date:  2017-06-30       Impact factor: 2.868

Review 4.  ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Nadja Smailagic; Marco Vacante; Chris Hyde; Steven Martin; Obioha Ukoumunne; Christos Sachpekidis
Journal:  Cochrane Database Syst Rev       Date:  2015-01-28

Review 5.  18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Gabriel Martínez; Robin Wm Vernooij; Paulina Fuentes Padilla; Javier Zamora; Leon Flicker; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

Review 6.  18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Gabriel Martínez; Robin Wm Vernooij; Paulina Fuentes Padilla; Javier Zamora; Leon Flicker; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

Review 7.  Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.

Authors:  Hilary A Archer; Nadja Smailagic; Christeena John; Robin B Holmes; Yemisi Takwoingi; Elizabeth J Coulthard; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2015-06-23

8.  Persistence of neuropsychological testing deficits in mild cognitive impairment.

Authors:  Edmond Teng; Kathleen D Tingus; Po H Lu; Jeffrey L Cummings
Journal:  Dement Geriatr Cogn Disord       Date:  2009-08-26       Impact factor: 2.959

Review 9.  18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Gabriel Martínez; Robin Wm Vernooij; Paulina Fuentes Padilla; Javier Zamora; Xavier Bonfill Cosp; Leon Flicker
Journal:  Cochrane Database Syst Rev       Date:  2017-11-22

Review 10.  Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review.

Authors:  Michele L Ries; Cynthia M Carlsson; Howard A Rowley; Mark A Sager; Carey E Gleason; Sanjay Asthana; Sterling C Johnson
Journal:  J Am Geriatr Soc       Date:  2008-04-09       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.